Dow Up 0.07% Nasdaq Down 0.00%

More On XTLS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Xstelos Holdings, Inc. (XTLS)

-Other OTC
0.43 0.00(0.00%) Sep 22
Prev Close:0.43
Open:0.43
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:0.733
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.37 - 8.00
Volume:0
Avg Vol (3m):3,339
Market Cap:N/A
P/E (ttm):143.33
EPS (ttm):0.00
Div & Yield:0.30 (15.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Xstelos Holdings, Inc. operates a specialty pharmaceutical company in the United States. Its principal product includes Testim, a gel for testosterone replacement therapy. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback